Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PYRROLOPYRIMIDINE DERIVATIVE AS WEE-1 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2022/228512
Kind Code:
A1
Abstract:
Disclosed is a pyrrolopyrimidine derivative as a Wee-1 inhibitor. Specifically, the present invention relates to a compound as represented by a general formula (1); a preparation method therefor; and the use of the compound of general formula (1), and isomers, crystal forms, a pharmaceutically acceptable salt, a hydrate or a solvate thereof as a Wee-1 inhibitor in the preparation of antitumor drugs.

Inventors:
XIE YULI (CN)
FAN HOUXING (CN)
QIAN LIHUI (CN)
Application Number:
PCT/CN2022/089864
Publication Date:
November 03, 2022
Filing Date:
April 28, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN)
International Classes:
C07D487/04; A61K31/519; A61P35/00; C07D471/00; C07D487/00
Domestic Patent References:
WO2021074251A12021-04-22
Foreign References:
CN110467615A2019-11-19
CN111718348A2020-09-29
CN110691782A2020-01-14
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: FUSED RING COMPOUND AS WEE-1 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Next Patent: DATA TRANSMISSION METHOD AND APPARATUS, AND DEVICE AND STORAGE MEDIUM